Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tuula Rintala"'
Autor:
Amal Alseraihy, Eoin McGrath, Dietger Niederwieser, Christian Chabannon, Jeff Szer, Mohamad Mohty, Mohamed A. Kharfan-Dabaja, Kim Orchard, Joseph Schwartz, Walid Rasheed, Mickey Koh, Nicolaus Kröger, Yoshihisa Kodera, Riad El Fakih, Nina Worel, Lynn Manson, Tuula Rintala, Abdelghani Tabakhi, Bipin Savani, Usama Gergis, Anna Sureda, Paul W. Eldridge, Ibrahim Yakoub‐Agha, Mehdi Hamadani, Daniel Weisdorf, Hildegard Greinix, Mahmoud Aljurf
Publikováno v:
Transplantation and Cellular Therapy. 28:455-462
Hematopoietic stem cell transplantation (HSCT) represents an example of a highly complex and costly medical procedure with major applications in hematology and oncology. It is associated with life-threatening complications and, consequently, increase
Autor:
Nina Worel, Andreas Holbro, Hans Vrielink, Claudia Ootjers, Kaatje Le Poole, Ingrid Beer-Wekking, Tuula Rintala, Miquel Lozano, Halvard Bonig
Publikováno v:
Bone Marrow Transplantation.
Autor:
Riccardo Saccardi, Hein Putter, Dirk-Jan Eikema, María Paula Busto, Eoin McGrath, Bas Middelkoop, Gillian Adams, Marina Atlija, Francis Ayuketang Ayuk, Helen Baldomero, Yves Beguin, Rafael de la Cámara, Ángel Cedillo, Anna María Sureda Balari, Christian Chabannon, Selim Corbacioglu, Harry Dolstra, Rafael F. Duarte, Rémy Dulery, Raffaella Greco, Andreu Gusi, Nada Hamad, Michelle Kenyon, Nicolaus Kröger, Myriam Labopin, Julia Lee, Per Ljungman, Lynn Manson, Florence Mensil, Noel Milpied, Mohamad Mohty, Elena Oldani, Kim Orchard, Jakob Passweg, Rachel Pearce, Régis Peffault de Latour, Hélène A. Poirel, Tuula Rintala, J. Douglas Rizzo, Annalisa Ruggeri, Carla Sanchez-Martinez, Fermin Sanchez-Guijo, Isabel Sánchez-Ortega, Marie Trnková, David Valcárcel Ferreiras, Leonie Wilcox, Liesbeth C. de Wreede, John A. Snowden
Publikováno v:
Bone Marrow Transplantation, 58, 659-666
Bone Marrow Transplantation, 58, 6, pp. 659-666
Bone Marrow Transplantation, 58, 6, pp. 659-666
Contains fulltext : 293484.pdf (Publisher’s version ) (Open Access) From 2016 EBMT and JACIE developed an international risk-adapted benchmarking program of haematopoietic stem cell transplant (HSCT) outcome to provide individual EBMT Centers with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b83d9778d232bf48a295ee0ab2e4b76
http://hdl.handle.net/2066/293484
http://hdl.handle.net/2066/293484